Pieris Pharmaceuticals

About:

Pieris Pharmaceuticals is a clinical-stage biotechnology company applying its proprietary.

Website: http://www.pieris.com

Top Investors: OrbiMed, Samsara BioCapital, Biotechnology Value Fund, Seagen, EcoR1 Capital

Description:

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Anticalins are recombinantly engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. Our libraries of more than 100 billion different Anticalins can virtually bind to any target of interest.